Cyclopharm secures maximum US patent extension for Technegas to 2031 – Biotech Dispatch
Cyclopharm secures maximum US patent extension for Technegas to 2031 Biotech Dispatch
In: PATENT NEWS
Cyclopharm secures maximum US patent extension for Technegas to 2031 Biotech Dispatch
In: PATENT NEWS
Nura Labs Files Revolutionary Patent: AI-Powered Wallet Solves the $180 Billion Crypto Staking Complexity Crisis The Manila Times
In: PATENT NEWS
Fed. Circ. Backs PTAB Invalidation Of Agilent CRISPR Patents Law360
In: PATENT NEWS
Thirty attorneys from global law firm Greenberg Traurig, LLP are recognized in Managing Intellectual Property magazine’s 2025 edition of “IP Stars …
In: PATENT NEWS
US Appeals Court Confirms Patent Validity of Acadia’s Parkinson’s Medication Insider Monkey
In: PATENT NEWS
US Appeals Court Confirms Patent Validity of Acadia’s Parkinson’s Medication Yahoo Finance
In: PATENT NEWS
Indian-origin autistic teen seeks US patent for universal human invention using AI MSN
In: PATENT NEWS
The court dismissed for lack of subject matter jurisdiction Neurocrine Biosciences Inc.’s action seeking a declaratory judgment invalidating …
In: PATENT NEWS
IAM Patent writes that he has “experience at any level of patent litigation” and “provides comprehensive and proactive legal support. … patent law.
In: PATENT NEWS
… presence in intellectual property law. The firm’s strategic positioning across key jurisdictions, combined with its team of highly qualified patent …
Designed by Industrial Action
Copyright © 2025 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION